SYMCEL
Apply for demo
  • calScreener™
    • Product Suite
    • Technology
  • Applications
    • Microbiology
      • Biofilm
      • Clinical Applications
      • Complex Models
      • Fungi
      • Antimicrobials Development
    • Probiotics & Microbiome
    • Thermogenesis
    • Cancer Biology
    • Horizon 2020
  • Learning Center
    • Publications
    • Testimonials
    • Science Blog
    • Data analysis tool
  • News
  • About Us
    • Team
    • Board
    • Scientific Advisors
    • Careers
  • Contact
    • General Inquiries
    • Service & Support
  • calScreener™
    • Product Suite
    • Technology
  • Applications
    • Microbiology
      • Biofilm
      • Clinical Applications
      • Complex Models
      • Fungi
      • Antimicrobials Development
    • Probiotics & Microbiome
    • Thermogenesis
    • Cancer Biology
    • Horizon 2020
  • Learning Center
    • Publications
    • Testimonials
    • Science Blog
    • Data analysis tool
  • News
  • About Us
    • Team
    • Board
    • Scientific Advisors
    • Careers
  • Contact
    • General Inquiries
    • Service & Support
Brown fat treatment research using isothermal microcalorimetry
5 Sep
Brown fat treatment research using isothermal microcalorimetry

Our colleague Dr. Karin Gillner recently had a feature article on brown fat treatment research published in Journal for Clinical Studies.

New board members bolstering expansion into diagnostics market
27 Jun
New board members bolstering expansion into diagnostics market

Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market

Karolinska Institutet to clinically validate calScreener™ for AST
11 Apr
Karolinska Institutet to clinically validate calScreener™ for AST

Internationally renowned clinical microbiologist takes academic lead in Horizon 2020 funded validation of game-changing method for multiple antibiotic resistance evaluation 11 April 2018: Symcel – the company behind the revolutionary cell-based...

8 Apr
Symcel expands staff to promote clinical market growth

L-R: Dr Marta Veses Garcia, Pelle Friberg and Dr Karin Gillner Symcel – producers of the cell-based assay tool for real-time cell metabolism measurements, calScreener — is expanding to bring its patented technology to the clinical antimicrobial...

6 Apr
Symcel Secures €3.6M for Antibiotic Susceptibility Testing

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing. Multi-resistant bacterial sepsis infections to be validated utilising Symcel’s sensitive screening technology Symcel:...

3 Apr
Jesper Ericsson appointed new CEO of Symcel

Symcel AB today announces the appointment of Jesper Ericsson as new Chief Executive Officer – succeeding Christer Wallin who is now retiring. 1 September 2017: Symcel has today announced that Jesper Ericsson has joined Symcel as Chief Executive...

  • 1 2 3
SYMCEL

info@symcel.com

Tomtebodavägen 6, 171 65, Stockholm, Sweden

BSI ISO Certification